Zentalis Pharmaceuticals, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
ZNTL on Nasdaq
Industry
Pharmaceutical Preparations
Location
10275 Science Center Drive, Suite 200, San Diego, CA

Insiders trading volume in the past year

Zentalis Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Matrix Capital Management Company, LP 10%+ Owner $144M Jun 20, 2023
Anthony Y. Sun President & CEO, Director $32.3M Apr 4, 2022
Kevin D. Bunker Chief Scientific Officer $15.1M Dec 20, 2023
Iris Roth Chief Operating Officer $14.8M Mar 1, 2023
Cam Gallagher President, Interim CFO, Director $7.59M May 31, 2024
Kimberly Blackwell Chief Executive Officer, Director $5.66M Feb 1, 2024
Melissa Epperly Chief Financial Officer $5.16M Feb 12, 2024
Diana Hausman Chief Medical Officer $4.72M May 9, 2024
Carrie Brownstein Chief Medical Officer $2.22M Oct 4, 2023
Alexis Pinto Chief Legal Officer $2.07M Feb 10, 2022
Andrea Paul Chief Legal Officer $1.83M -$22.6K -1.22% Feb 3, 2025
Dimitris Voliotis SVP, Clinical Development $1.32M Feb 10, 2022
Mark Lackner Chief Scientific Officer $878K -$38.4K -4.19% Feb 3, 2025
Scott Myers Director $437K +$29.4K +7.21% Jun 17, 2025
Vincent Vultaggio PAO and Interim PFO $325K -$4.48K -1.36% Feb 3, 2025
David M. Johnson Director $323K Jun 17, 2025
Jan Skvarka Director $267K +$103K +63.2% Jun 17, 2025
Luke Walker Director $186K +$25K +15.5% Jun 17, 2025
Enoch Kariuki Director $177K Jun 17, 2025
Julia Marie Eastland CEO & President, Director $152K +$49.3K +48.3% Feb 3, 2025
Ingmar Bruns Chief Medical Officer $83.6K +$45.7K +120% Feb 6, 2025
James Bucher Chief Legal Officer Oct 1, 2025

Recent Insider Transactions by Companies or Individuals for Zentalis Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.